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Oxygen (O2) is an obligate element for cellular function and is thus of vital importance for the 
human body to sustain life. The delivery of O2 to the body (DO2) is dependent on the availability 
of O2 in blood (predominantly by arterial O2 saturation and hemoglobin concentration) and on the 
flow of blood, i.e. cardiac output (CO). Although one would intuitively assume that the cardiac pump 
itself is the main drive for blood flow, this is not entirely true as was demonstrated more than half 
a century ago by Arthur Guyton.1 Briefly, he demonstrated that venous return (VR) equals CO under 
steady state conditions and he found that decreasing or increasing VR caused changes in CO in the 
same direction, suggesting that VR is the main determinant of CO. He further demonstrated that 
VR is primarily determined by the generation of a pressure difference between the venous side of 
the circulation and the right side of the heart, which represents a “driving pressure” for the heart. 
Furthermore, VR can subsequently be influenced by two factors: 1) the resistance to blood flow, 
particularly of that of the peripheral circulation and 2) the degree of vascular filling, called the mean 
systemic filling pressure (Pmsf).2 Pmsf is the theoretical pressure within the entire circulation that 
would exist after blood circulation has stopped and pressures within the arterial and venous side 
of the circulation have equilibrated. Pmsf can be influenced both by the amount of intravascular 
volume, but also by the capacitance of the vascular system. This means that, for example, vasodilation 
and/or hypovolemia will decrease Pmsf while vasoconstriction and/or increasing blood volume will 
increase Pmsf. Another important physiologic aspect is that increased myocardial stretch leads 
to an increased force of myocardial contraction, and thus the heart is “inclined” to pump out the 
amount of blood that is being offered to it. In other words, this means that increasing venous return 
(“cardiac preload”) increases stroke volume (SV) automatically, which is termed the “Frank-Starling 
mechanism” (figure 1).3 The Frank-Starling curve of an individual patient is however not static and 
its shape can differ, depending on systolic cardiac function, diastolic compliance and the degree of 
cardiac afterload. The resulting combination of these factors determines the shape of the individual 
Frank-Starling curve, and the amount of preload (or: VR) determines the actual point of the curve 
at which the heart is performing. Finally, CO is influenced by heart rate as CO is calculated as the 
product of heart rate and SV.




In patients undergoing anesthesia or in critically ill patients, any hemodynamic intervention is 
essentially aimed to optimize DO2 . Providing sufficient DO2 is ultimately aimed at improving 
the microcirculation, as microcirculatory dysfunction and subsequently cellular dysfunction 
primarily determines the development of complications.4 Clinical measurement of microcellular 
dysfunction, as well as global DO2, is however difficult, which is the reason why thus far, only macro- 
hemodynamics are measured instead as surrogate. Therefore, the mainstay of hemodynamic 
monitoring is accomplished by measuring one or more of the three main modalities of cardiovascular 
physiology: blood pressure, blood flow and blood volume.
 
Basic,	pressure-based	hemodynamic	monitoring
For years, anesthesiologists partly rely on clinical signs for quickly assessing hemodynamics, e.g. 
skin color, capillary refill and impression of peripheral pulsation(s). In addition to these clinical signs, 
cardiopulmonary function is continuously monitored by electrocardiography and by measurement 
of arterial oxygen saturation (SpO2) using plethysmography. In addition, intermittent arterial blood 
pressure measurement accomplishes basic hemodynamic monitoring. 
In most patients under (general) anesthesia, arterial blood pressure (ABP) measurement is performed 
noninvasively using arm cuff oscillometry with a time-interval of 3 - 5 minutes. While this method 
is not considered harmful and is easy to perform, it only provides “snap shot” measurement of ABP 
and its accuracy and precision can be decreased by factors such as (in)correct cuff size, (in)correct 
positioning and obesity.5,6 Also, hypotensive episodes might be missed7, and frequently systolic and 
diastolic values can deviate from true values during hypo- and hypertensive episodes.8 Finally, cuff 
deflation can lead to a substantial time-bias between systolic and diastolic values as it arises from 
different heartbeats.9 Therefore, if it is deemed necessary to continuously or accurately and precisely 
monitor arterial blood pressure, an arterial catheter is usually placed, which allows continuous 
monitoring of the arterial pressure waveform and subsequent calculation of ABP. The placement 
of an arterial catheter can however be painful in an awake patient, can be time-consuming also 
and can cause several complications.10,11 Recently, the volume clamp technique has become clinically 
available. This noninvasive technique uses a combination of plethysmography with an inflatable 
finger cuff, of which the pressure is adjusted with high frequency in order to keep the arterial volume 
constant (a method called “volume clamping”). Recording of the cuff pressure allows reconstruction 
of the brachial artery waveform with associated, continuous calculation of ABP. Multiple studies 
have already investigated the agreement of volume clamp derived ABP with invasively derived ABP, 
with somewhat conflicting results.12 As ABP is monitored in the majority of patients solely using 
intermittent noninvasive cuff oscillometry measurements, the interchangeability of this method 
with volume clamp derived ABP values is of relevance if one considers the volume clamp method 
as an alternative for cuff oscillometry. Therefore, in chapter 1, in patients under general anesthesia, 
a comparison is made between these methods, and the agreement of both methods with the gold 
standard (invasively derived ABP measurement) as a reference is investigated.
Advanced,	flow-based	hemodynamic	monitoring
Advanced hemodynamic monitoring mainly consists of measuring CO or other blood flow-related 
variables as a surrogate and traditionally requires invasive procedures for its monitoring. The clinical 
gold standard for monitoring of CO is thermodilution using the pulmonary artery catheter (PAC), in 
which a fixed volume of cold fluid is injected into the right atrium, after which the resulting decreases 
in blood temperature are recorded in the pulmonary artery. The area under the thermodilution curve 










Part A Part B 
monitoring is generally regarded too invasive, as it is associated with serious complications and 
moreover, its routine use has not been proven to improve patient outcome.13 
Technologic advances in the last decade facilitated the trend for performing advanced hemodynamic 
monitoring in a less invasive fashion. As such, alternative and less invasive methods of CO-
monitoring have been developed which are frequently based on arterial pulse contour analysis. 
These techniques perform a continuous analysis of the arterial pressure waveform for calculation 
of SV and CO (requiring an arterial catheter). Importantly, these techniques require some form of 
calibration for vascular resistance and the calibration method ultimately determines its invasive 
character. E.g., some devices require transpulmonary (thermo)dilution for calibration (requiring a 
central venous line), some injection of an indicator using only a peripheral line (e.g. lithiumchloride) 
and another device performs an algorithm-based auto-calibration. 
In addition, even completely noninvasive techniques have become available for monitoring CO, for 
which multiple methods exists. The previously described volume clamp technique is an example. 
This technique requires only a finger cuff, and the reconstructed brachial arterial waveform is used 
for calculation of stroke volume, which after multiplying with heart rate, gives CO.14 The development 
of CO-monitoring techniques ranging from minimally invasive to noninvasive potentially allows 
optimization of blood flow in patients in whom otherwise predominantly pressure-based monitoring 
would be applied. An important way for optimization of CO can be accomplished by increasing 
cardiac preload by fluid administration. Though, apart from monitoring CO itself, it may be even 
more important to predict whether CO can be optimized, i.e. whether CO will increase following 
administration of fluid. An important mechanism responsible for increasing cardiac output in 
response to increasing cardiac preload, is the Frank-Starling mechanism as explained earlier (figure 
1). The Frank-Starling curve consists of a steep and flat part. In case of decreased intravascular volume, 
the patient is likely to be on the steep part of the Frank-Starling curve (Part A, figure 2) and increasing 
venous return by administration of fluid will increase SV. In this case, the patient is recognized as 
a “fluid responder”. In case the patient is on the flat part of the Frank-Starling curve (Part B, figure 
2), administration of additional fluid will not increase SV, and the patient will be regarded a “non-
responder” to fluid. The determination whether a patient is presumably a responder or non-responder 
to fluid administration is an important part of hemodynamic monitoring and optimization, which 
requires that CO be monitored. Ideally, one should be able to optimize CO (not maximize; the lighter 
colored part of the curve in figure 2	 represents the optimal range of CO values), as inadvertent 
administration of ‘too much’ fluid can lead to complications such as pulmonary edema and cardiac 
decompensation. On the other hand, withholding the hypovolemic patient fluid also makes the 
patient prone to development of serious complications related to organ hypoperfusion.15
Introduction
Figure 2: Simplified Frank-Starling curve, which 
demonstrates the relationship between preload and 
stroke volume. In Part A, the patient is on the steep 
part of the curve and will be fluid-responsive. In part 
B, the patient is on the flat part of the curve, and will 
not be a fluid-responder.
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In addition, e.g. in case of surgical blood loss, a patient in the “responder” zone might be at a much 
higher risk of hemodynamic collapse than a patient in the “non-responder” zone. In anticipation to 
such events, one could suggest that the patient should be brought into the safer, non-responder 
zone.
Traditionally, static indicators of cardiac preload, like central venous pressure (CVP; requires a 
central venous line) or pulmonary artery occlusion pressure (PAOP; requires PAC placement) were 
used.16 These static preload variables have however been shown to be incompetent in predicting 
fluid responsiveness.17,18,19 Instead, dynamic preload variables, which are based on the heart-lung 
interaction, have been shown to be superior to these static preload variables in predicting fluid 
responsiveness.20,21-28 In volume-controlled mechanically ventilated patients, the intermittent 
ventilator-induced increases in intrathoracic pressure can cause temporary alterations in stroke 
volume. In case of hypovolemia, stroke volume will be influenced substantially by in- and expiration, 
causing a large variation, while in case of normo- or hypervolemia the variation of stroke volume 
will be minimal.29 The resulting variation over time in e.g. pulse pressure or stroke volume, can be 
calculated from the recorded arterial pressure waveform, yielding pulse pressure variation (PPV) or 
stroke volume variation (SVV), respectively. Recent technologic advances allow calculation of dynamic 
preload variables not only from the arterial pressure waveform, but also completely noninvasively 
using variations in the plethysmographic waveform (plethysmographic variability index, PVI). 
It is important to assess whether the adequacy of predicting fluid responsiveness by noninvasive 
dynamic preload variables (e.g. PVI) is comparable to that of invasively obtained dynamic preload 
variables (e.g. PPV, SVV). Therefore, in chapter 2, a comparison is made between dynamic preload 
variables derived from the (minimally invasive) arterial pressure waveform and from those derived 
noninvasively, for the ability to predict fluid responsiveness in patients undergoing major hepatic 
resection. It is also assessed in this chapter, whether these variables are able to track changes induced 
by fluid administration, which would be an important prerequisite if dynamic preload variables were 
used solely without actual CO monitoring. In addition, in chapter 2, a method to assess changes 
in arterial elastance, i.e. vascular tone, is investigated. Here, the ratio was calculated between PPV 
(pressure-based) and SVV (flow-based), which is called the dynamic arterial elastance (Eadyn)
30 and it 
was investigated whether using this variable, dosage changes of norepinephrine could be assessed 
during the administration of fluid.
An important issue in the analysis of the ability of dynamic preload variables to predict fluid 
responsiveness is that, in general, a distinct threshold is chosen to define fluid responsiveness, which 
renders the analysis of fluid responsiveness binary: a patient is regarded either a fluid-responder or 
a non-responder. The so called grey zone analysis has been designed to overcome the traditional 
binary character31 of the analysis of fluid responsiveness.31,32 The grey zone consists of a range of 
values of dynamic preload variables that give no clear information whether or not the patient is to 
be regarded fluid responsive. In addition, a wide range of thresholds is chosen in the literature for 
the definition of fluid responsiveness, which troubles a sound comparison of studies investigating 
the issue of fluid responsiveness. Therefore, in chapter 3, the adequacy of PPV and SVV, noninvasively 
derived using the volume clamp method, is assessed for multiple thresholds of fluid responsiveness 
using the grey zone approach.
Quantification	of	blood	volume	and	its	distribution
The volume of intravascular blood is an important determinant for the degree of vascular filling 
and hence, is a main determinant of venous return of blood to the heart. While dynamic preload 
variables can predict fluid responsiveness, they do not provide a direct quantification of blood 
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volume. Unfortunately though, clinical measurement of blood volume is more difficult than the 
measurement of either blood flow or blood pressure and requires the use of indicator-dilution 
techniques, which are in general invasive.33-35 
Nevertheless, for a sound understanding of cardiovascular physiology under various clinical 
circumstances, an accurate and precise assessment of (compartments of) blood volume is essential, 
despite the required invasive methods required for this. Essentially, the indicator-dilution technique 
is based on the measured dilution curve of an intravenously injected dye, by which the mean 
transit time (mtt) of that dye between site of injection (venous side, mostly right atrium) and site 
of measurement (arterial side) can be calculated.33 The mtt multiplied by CO yields the volume of 
blood between these sites. As such, total intravascular blood volume can be divided into multiple 
compartments, of which circulating blood volume (Vd circ)
35 and central blood volumes (pulmonary 
and intrathoracic blood volume: PBV and ITBV, respectively) are clinically the most relevant 
compartments and can all be calculated using the indicator-dilution technique. In individuals 
in whom fluid alterations occur, i.e. hypovolemia due to hemorrhage or hypervolemia due to 
excessive fluid administration, it is often stated that – especially under hypovolemic conditions –the 
cardiovascular system regulates blood flow to these central blood compartments at the cost of the 
peripheral blood compartment. However, an investigation of the relationship between central blood 
volumes (PBV, ITBV) and Vd circ (which includes both the central and peripheral blood volume) has 
never been the subject of investigation. Therefore in chapter 4, to provide a better understanding of 
the circulatory effects of hypo- and hypervolemia, the relationship between central blood volumes 
and Vd circ was investigated in spontaneously breathing anesthetized dogs in which blood volume 
was altered to create situations of both hypo- and hypervolemia.
While the procedures required for measuring the various blood volumes described in chapter 4 
are highly invasive, a very different method has recently become available – not to assess blood 
volume itself – but to assess the degree of intravascular volume in terms of the mean systemic 
filling pressure (Pmsf, see above) as an indirect surrogate of effective circulating blood volume.36 
Direct measurement of Pmsf would require circulatory arrest, making it clinically impossible to 
measure it. Instead, an algorithm has been developed, which uses demographic parameters and 
hemodynamic variables (MAP, CO, CVP) to estimate Pmsf.36,37 Additionally, this algorithm calculates 
the proposed “driving” pressure for venous return (Pvr; i.e. Pmsf minus CVP). Also, another variable, 
heart performance (EH; calculated as Pvr / Pmsf) is proposed to allow a quantification of the ability of 
the heart to generate cardiac output from venous return. Previous work demonstrated that variables 
derived from this algorithm correlated with expected changes following fluid administration – at 
least in post-cardiac surgery patients.36 It has however not been well studied yet, whether Pvr allows 
an adequate prediction of fluid responsiveness. Therefore, in chapter 5, the ability of Pvr in predicting 
fluid responsiveness is compared with that of the established dynamic preload variables PPV and 
SVV. In addition, this chapter was aimed to elucidate the changes in Pmsa, Pvr and EH following fluid 
administration to further distinguish fluid responders from non-responders.
Noninvasive	assessment	of	another	DO2-determinant:	Hb	concentration
DO2 is not only determined by cardiac output, but also by Hb concentration and its saturation with 
oxygen (SaO2). Therefore, especially in the perioperative setting, Hb concentration should not be 
allowed to decrease below a certain threshold, which is equivalent to the individual transfusion 
trigger. Traditionally, Hb concentration is determined intra-operatively using satellite laboratory 
blood gas analysis (Hbsatlab). Recently though, new technology has become available, which allows 
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measurement of Hb transcutaneously (SpHb) using multi-wavelength pulse co-oximetry.38,39 
Importantly, the agreement of noninvasive SpHb with established methods for measuring Hb 
concentration is to be determined. Therefore, in chapter 6, its accuracy and precision is investigated 
in patients undergoing extensive liver surgery during both a static phase without alterations in fluid 
administration, and in a dynamic phase in which patients received per randomization either a bolus 
of crystalloid or colloid fluids.
Minimally	invasive	assessment	of	liver	function:
Finally, this thesis is not only aimed at (minimally or noninvasively) monitoring of (macro-) 
hemodynamics, but also at organ specific monitoring, particularly the minimally invasive monitoring 
of liver function. Assessment of liver function by clinical examination, laboratory findings and 
radiologic imaging is difficult, especially perioperatively in patients undergoing liver transplantation 
or major hepatic resection.40 In this context, measurement of the elimination of the dye indocyanine 
green (ICG) has been used since many years to assess liver function.41 ICG is exclusively eliminated 
by the liver without metabolisation into the bile, i.e. without enterohepatic recirculation. In addition, 
the hepatic elimination ratio of ICG is high and therefore, in case of stable hemodynamics, allows 
quick assessment of liver function. Nowadays, ICG elimination can be assessed in a minimally 
invasive fashion by pulse dye densitometry, in which the elimination phase of the ICG-dilution curve 
represents hepatic elimination of ICG.42,43 The measurement of ICG elimination by transcutaneous 
pulse dye densitometry allows monitoring liver function in a bedside manner. Nevertheless, it has 
not gained uniform acceptance for routine liver function monitoring. Chapter 7 provides a review on 
the current clinical applications of ICG, relevant to the anesthesiologist in several settings. First, this 
chapter reviews the role of ICG perioperatively in liver transplant patients and in patients scheduled 
to undergo major hepatic resection. Second, this chapter reviews the role of ICG in critically ill patients 
with acute liver failure, intra-abdominal hypertension or for non-specific mortality prediction in ICU 
patients. 
As measurement of ICG elimination could provide a direct bedside assessment of liver function, it 
might also allow an early assessment of graft function intra-operatively during liver transplantation. 
In chapter 8, it is investigated whether measurement of ICG elimination in patients undergoing 
orthotopic liver transplantation can predict the absence of early postoperative complications.
The	aims	of	this	thesis:
This thesis is aimed at investigating the adequacy and reliability of minimally invasive monitoring in 
anesthesia. The main approach is to compare “less” invasively derived variables with its established, 
“more” invasively derived counterparts in patients under general anesthesia. More specifically, the 
following domains are the subjects of investigation in this thesis:
The prediction of fluid responsiveness and the assessment of tracking fluid-induced changes, 
using noninvasively derived dynamic preload variables. These variables are compared with 
the established arterial-pressure based dynamic preload variables. Also, the use of the ratio of 
pressure-based PPV and flow-based SVV (Eadyn, dynamic arterial elastance) in assessing vascular 
tone is investigated.
The influence of the threshold for the definition of fluid responsiveness on its prediction by 
dynamic preload variables is investigated, including the associated ranges of inconclusive values 
of dynamic preload variables for these thresholds.
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The interchangeability between measurement of ABP by conventional intermittent cuff 
oscillometry and continuous volume clamping is assessed. The agreement of both methods is 
tested with the gold standard, invasively derived ABP values, as a reference.
An assessment of the agreement of SpHb values with Hbsatlab values during static and dynamic 
conditions in patients undergoing liver surgery is provided. Additionally, the effect of crystalloids 
and colloids on SpHb agreement is investigated.
The changes in minimally invasive assessment of Pmsf and Pvr in patients undergoing liver 
surgery receiving fluid administration are assessed. Also, a comparison between the ability of 
Pvr and dynamic preload variables to predict fluid responsiveness is performed.
An assessment of changes in the relationship between effective circulating blood volume and 
central blood volumes during hypo- and hypervolemia is provided for a better understanding of 
the physiologic effects of these situations on hemodynamics.
The minimally invasive assessment of liver function using ICG elimination measurements 
during orthotopic liver transplantation and its prediction of postoperative liver function is 
assessed, together with providing an overview of the use of ICG for liver function monitoring 
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